KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $30,149,000 | -52.1% | 402,209 | -51.9% | 0.00% | -42.9% |
| Q2 2015 | $62,975,000 | +78.7% | 836,191 | +19.0% | 0.01% | +75.0% |
| Q1 2015 | $35,232,000 | +39.4% | 702,581 | -3.6% | 0.00% | +33.3% |
| Q4 2014 | $25,273,000 | +16.7% | 728,816 | +10.2% | 0.00% | +50.0% |
| Q3 2014 | $21,664,000 | -10.6% | 661,370 | +4.7% | 0.00% | -33.3% |
| Q2 2014 | $24,230,000 | +8.9% | 631,392 | +12.8% | 0.00% | 0.0% |
| Q1 2014 | $22,257,000 | -0.2% | 559,731 | -8.1% | 0.00% | +200.0% |
| Q4 2013 | $22,307,000 | +275.7% | 609,282 | +369.0% | 0.00% | 0.0% |
| Q3 2013 | $5,938,000 | +194.0% | 129,903 | +73.8% | 0.00% | – |
| Q2 2013 | $2,020,000 | – | 74,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,382,722 | $69,344,000 | 3.43% |
| Versant Venture Management, LLC | 70,376 | $3,529,356,000 | 3.10% |
| AlpInvest Partners B.V. | 29,731 | $1,491,000 | 2.79% |
| Partner Investment Management, L.P. | 29,178 | $1,463,000 | 2.20% |
| PFM Health Sciences, LP | 1,242,509 | $62,312,000 | 1.72% |
| Aureus Asset Management, LLC | 130,307 | $6,535,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 444,999 | $22,317,000 | 1.49% |
| HealthCor Management, L.P. | 425,000 | $21,314,000 | 1.02% |
| Redmile Group, LLC | 225,062 | $11,287,000 | 1.01% |
| REGENTATLANTIC CAPITAL LLC | 174,454 | $8,749,000 | 0.77% |